NADER NOORIAN: Open Payments
NPI 1861479057 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,122 in 236 payments from 30 companies in 2025. Trend: 2023 $3,708 · 2024 $7,479 · 2025 $8,122
Food & beverage: $6,442Speaker / faculty: $1,600Education: $80
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $2,612 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 23 | $812 |
| Otsuka America Pharmaceutical, Inc. | 17 | $633 |
| Novo Nordisk Inc | 22 | $512 |
| ABBVIE INC. | 20 | $430 |
| Aimmune Therapeutics, Inc. | 17 | $419 |
| Novartis Pharmaceuticals Corporation | 23 | $394 |
| Corcept Therapeutics | 15 | $377 |
| Lilly USA, LLC | 21 | $367 |
| Edwards Lifesciences Corporation | 3 | $258 |
Products named: AIRSUPRA, JARDIANCE, REXULTI, BREZTRI, ZENPEP, LEQVIO, Korlym, FARXIGA.
Industry payments across CA — which companies pay providers there.
